Leuven: Every seven years Europe rewrites the rulebook for how it funds the laboratories, start-ups and grand collaborations that are supposed to keep the continent in the scientific race, and the next edition is now the subject of a long, consequential argument. The successor to the current research programme, which runs out in 2027, will keep the familiar Horizon Europe name but arrives with a far heavier wallet. The Commission has proposed a budget of one hundred and seventy-five billion euros for the years from 2028, almost double the current envelope, and a new structure built around four pillars instead of three.
The headline figure is less settled than it looks. A proposal is an opening bid, and the years until adoption are a tug of war between a Commission that wants to signal ambition, capitals that guard their contributions jealously, and a Parliament that tends to push for more research money than either. In the spring two of the Parliament’s lead negotiators published their draft reports on the plan, the formal starting gun for amendments, and the institution is widely expected to argue that even a near-doubled budget falls short of what global competition demands. The Council, mindful of every other claim on a stretched common budget, will pull the other way.
The structural change matters as much as the money. The current programme rests on three pillars, one for blue-sky science, one for the great societal challenges from health to climate, and one for turning ideas into businesses. The new design adds a fourth dedicated to the European Research Area, the long-running effort to knit twenty-seven national research systems into something that behaves more like a single one, so that a grant, a researcher or a piece of equipment can move across borders without friction. Whether a fourth pillar strengthens that goal or simply adds a layer of administration is one of the quieter disputes inside the larger budget fight.
Beneath the institutional choreography sits a real anxiety. Europe publishes excellent science and struggles to turn it into companies that scale, watching too many of its brightest ideas migrate to better-capitalised markets abroad. Advocates for a generous programme argue that research is the one budget line that pays for itself in growth, and that trimming it to satisfy short-term fiscal caution is a false economy the continent cannot afford. Sceptics counter that money already flows through layers of bureaucracy so dense that researchers spend more time writing applications than experiments, and that reform of how the cash is spent should come before any boast about how much there is.
The negotiation now entering its decisive phase will shape which view prevails, and with it the texture of European research for the better part of a decade. The decisions taken in the coming months, on the size of the purse, the shape of the pillars and the rules that govern access, will determine whether a scientist in a mid-sized university town finds the next framework programme an open door or another maze. For all the talk of strategic autonomy and technological sovereignty, it comes down to something concrete, whether Europe is willing to back its laboratories with the kind of money its rivals already take for granted.
